Related Experiment Video

Updated: May 21, 2026

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Stem cells. Antipsychotic to anticancer agent?

Darren J Burgess

    Nature Reviews. Cancer
    |June 23, 2012
    PubMed

    Insights

    A new study reveals a clinically approved drug can selectively target cancer stem cells, prompting their differentiation. This finding offers a promising new avenue for cancer therapy development.

    Area of Science:

    • Oncology
    • Cancer Stem Cell Biology
    • Drug Discovery

    Background:

    • Cancer stem cells (CSCs) are crucial drivers of tumor initiation, metastasis, and therapeutic resistance.
    • Identifying selective CSC-targeting agents is a major challenge in cancer research.
    • Existing therapies often fail to eradicate CSCs, leading to relapse.

    Discussion:

    • This study investigates the potential of a clinically approved drug to induce differentiation in CSCs.
    • The drug demonstrated selective action against CSCs, sparing normal stem cells.
    • Differentiation effectively neutralizes the self-renewal and tumorigenic potential of CSCs.

    Key Insights:

    • A repurposed drug shows selective efficacy against cancer stem cells.
    • Inducing CSC differentiation offers a novel therapeutic strategy.
    • This approach may overcome resistance mechanisms associated with CSCs.

    Outlook:

    • Further preclinical and clinical studies are warranted to validate this therapeutic approach.
    • This finding could pave the way for novel combination therapies targeting CSCs.
    • The selective targeting of CSCs represents a significant advancement in precision oncology.

    More Related Videos

    Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies12:13

    Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

    Published on: July 11, 2019

    A Guide to Generating and Using hiPSC Derived NPCs for the Study of Neurological Diseases09:30

    A Guide to Generating and Using hiPSC Derived NPCs for the Study of Neurological Diseases

    Published on: February 21, 2015

    Related Concept Videos

    iPS Cell Differentiation01:22

    iPS Cell Differentiation

    The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
    Induced Pluripotent Stem Cells01:06

    Induced Pluripotent Stem Cells

    Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
    Somatic cells are...
    Induced Pluripotent Stem Cells01:13

    Induced Pluripotent Stem Cells

    Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
    EPS and iPS Cells in Disease Research01:21

    EPS and iPS Cells in Disease Research

    Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
    Mesenchymal Stem Cells01:19

    Mesenchymal Stem Cells

    Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
    Antipsychotic Drugs: Therapeutic Uses and Side Effects01:21

    Antipsychotic Drugs: Therapeutic Uses and Side Effects

    Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
    Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...